EUVIMEDEUVIMED entdecken
Open Access

V‐Set Immunoglobulin Domain–Containing Protein 4 as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology Activity

Chenling Tang, Shu Zhang, Aygun Teymur, Bowen Yang, Fariz Nazir, Qi Cai, Ramesh Saxena, Nancy J Olsen, Chandra Mohan, Tianfu Wu iD

Arthritis & Rheumatology · 2023-09 · 75 (9) · 1573-1585

DOI: 10.1002/art.42545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 04.07.2023. Verfasst von Chenling Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Houston, Houston, Texas. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Lupus Nephritis, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To discover novel serum biomarkers that have diagnostic or predictive value in lupus nephritis (LN).

Methods

Using a quantitative protein microarray, we screened for high‐abundant proteome expression in the serum of patients with LN compared to healthy controls. Top candidates from this screening were validated using a larger cohort of patients with LN compared to a disease control cohort (subjects with other chronic kidney diseases) and a healthy control cohort. Promising markers were then selected using a machine‐learning model and further validated with a larger patient cohort. The corresponding autoantibodies and immune complexes containing these proteins were also examined.

Results

In total, 13 proteins were found to be significantly elevated in LN patient serum in the screening, among which 8 proteins were validated by enzyme‐linked immunosorbent assay using 81 serum samples from LN patients and control subjects. Three serum markers with LN diagnostic potential were identified using feature importance analysis and further validated using 155 serum samples from LN patients and control subjects. V‐set immunoglobulin domain–containing protein 4 (VSIG4) appeared to be the most promising marker in distinguishing LN from healthy controls, with an area under the curve of 0.93. VSIG4 could also discriminate active LN from inactive LN. Furthermore, serum VSIG4 levels were positively correlated with all of the following clinical parameters: the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score (Spearman's rank correlation r s = 0.42, P < 0.001), the renal domain score of the SLEDAI (r s = 0.46, P < 0.001), the urinary protein‐to‐creatinine ratio (r s = 0.56, P < 0.001), and the serum creatinine level (r s = 0.41, P < 0.001). Importantly, we found that serum VSIG4 levels tracked with LN disease activity longitudinally, and that serum VSIG4 levels reflected the renal pathology activity index (AI), particularly the AI components of crescent formation and hyaline deposits.

Conclusion

VSIG4 may be a promising novel serum biomarker and therapeutic target in patients with LN. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicLupus NephritisRenal Insufficiency, ChronicHumansBiomarkersImmunoglobulin DomainsKidneyReceptors, Complement

Substanzen

BiomarkersVSIG4 protein, humanReceptors, Complement

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Houston, Houston, Texas.
  • Department of Pathology, University of Texas Southwestern Medical Center, Dallas.
  • Division of Nephrology, University of Texas Southwestern Medical Center, Dallas.
  • Division of Rheumatology, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.

ORCID-Profile: Tianfu Wu

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Tang, C., Zhang, S., Teymur, A., Yang, B., Nazir, F., Cai, Q., Saxena, R., Olsen, N. J., Mohan, C., & Wu, T. (2023). V‐Set Immunoglobulin Domain–Containing Protein 4 as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology Activity. Arthritis & Rheumatology, 75(9), 1573-1585. https://doi.org/10.1002/art.42545

Vancouver

Tang C, Zhang S, Teymur A, Yang B, Nazir F, Cai Q, et al. V‐Set Immunoglobulin Domain–Containing Protein 4 as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology Activity. Arthritis & Rheumatology. 2023;75(9):1573-1585. doi:10.1002/art.42545

BibTeX
@article{Tang2023,
  author = {Tang, Chenling and Zhang, Shu and Teymur, Aygun and Yang, Bowen and Nazir, Fariz and Cai, Qi and Saxena, Ramesh and Olsen, Nancy J and Mohan, Chandra and Wu, Tianfu},
  title = {V‐Set Immunoglobulin Domain–Containing Protein 4 as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology Activity},
  journal = {Arthritis & Rheumatology},
  year = {2023},
  volume = {75},
  number = {9},
  pages = {1573--1585},
  doi = {10.1002/art.42545}
}
Kostenlos starten →